Fingerprint
Dive into the research topics of 'Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically